MD2850G2 - Метод индукции медикаментозного аборта - Google Patents

Метод индукции медикаментозного аборта Download PDF

Info

Publication number
MD2850G2
MD2850G2 MDA20050046A MD20050046A MD2850G2 MD 2850 G2 MD2850 G2 MD 2850G2 MD A20050046 A MDA20050046 A MD A20050046A MD 20050046 A MD20050046 A MD 20050046A MD 2850 G2 MD2850 G2 MD 2850G2
Authority
MD
Moldova
Prior art keywords
medicamental
abortion
inducing
hours
administered
Prior art date
Application number
MDA20050046A
Other languages
English (en)
Romanian (ro)
Other versions
MD2850F1 (en
Inventor
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Original Assignee
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валентин ФРИПТУ, Виктор ГИКАВЫЙ, Людмила ФРИПТУ, Михаил ТОДИРАШ, Екатерина СТРАТУ, Корина КАРДАНЮК filed Critical Валентин ФРИПТУ
Priority to MDA20050046A priority Critical patent/MD2850G2/ru
Publication of MD2850F1 publication Critical patent/MD2850F1/xx
Publication of MD2850G2 publication Critical patent/MD2850G2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, в частности к акушерству и гинекологии и может быть использовано для прерывания беременности на малом сроке, а именно до 56 дней, ассоциированной с аменореей.Сущность изобретения состоит в том, что назначают per os 200 мг мифепристона, затем по истечении 24…48 часов назначают четырехкратно внутривлагалищно, через каждые 6 часов, по одному суппозиторию, содержащему 50 мг бромида S-этилизотиоурона (изотурон).
MDA20050046A 2005-02-18 2005-02-18 Метод индукции медикаментозного аборта MD2850G2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ru) 2005-02-18 2005-02-18 Метод индукции медикаментозного аборта

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ru) 2005-02-18 2005-02-18 Метод индукции медикаментозного аборта

Publications (2)

Publication Number Publication Date
MD2850F1 MD2850F1 (en) 2005-09-30
MD2850G2 true MD2850G2 (ru) 2006-07-31

Family

ID=35057541

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050046A MD2850G2 (ru) 2005-02-18 2005-02-18 Метод индукции медикаментозного аборта

Country Status (1)

Country Link
MD (1) MD2850G2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20070283A (ru) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Способ формирования зарядного тока для емкостного накопителя энергии
MD215Z (ru) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Зарядное устройство емкостного накопителя
MD4073C1 (ru) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Стабилизированный преобразователь высокого напряжения
MD281Z (ru) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Регулируемый резонансный преобразователь напряжения

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (ro) * 1995-03-01 1995-08-31 Victor GHICAVII Remediu cu actiune antihipotensiva "izoturon"
MD1223B1 (en) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof
MD1431F1 (en) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Antihypotensive remedies
MD2228F1 (en) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2323F1 (en) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MD2491F1 (en) * 2004-02-10 2004-07-31 Victor GHICAVII Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (ro) * 1995-03-01 1995-08-31 Victor GHICAVII Remediu cu actiune antihipotensiva "izoturon"
MD1223B1 (en) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof
MD1431F1 (en) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Antihypotensive remedies
MD2228F1 (en) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2323F1 (en) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MD2491F1 (en) * 2004-02-10 2004-07-31 Victor GHICAVII Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Schaff E., Fielding S., Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception. 2002 Oct; 66(4), p. 247-250 *

Also Published As

Publication number Publication date
MD2850F1 (en) 2005-09-30

Similar Documents

Publication Publication Date Title
Ellertson et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours
AR023129A1 (es) Composiciones para mejorar la fertilidad
BR0007360A (pt) Composição de liberação controlada
EA201200377A8 (ru) Способ пероральной контрацепции у женщин, способ управления нежелательными кровотечениями и предназначенная для применения в этих способах фармацевтическая упаковка
BR9509019A (pt) Processo para fabricar unidades de dosagem farmacêutica e comprimido isento de solventes orgânicos
PE20060127A1 (es) Sistema de entrega de farmacos constituido por copolimero de polietileno acetato de vinilo
BRPI0617683A2 (pt) processo para a contracepção hormonal preventiva segundo a necessidade e uso de um emplastro transdérmico
UY29527A1 (es) Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
MD2850G2 (ru) Метод индукции медикаментозного аборта
Rahayu et al. Effect of vitamin C on testosterone level, sperm count and sperm morphology in gentamicin-induced Wistar rats
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
Farajkhoda et al. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
Park et al. Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction
GB2407504A (en) Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
BOARD Endometrial carbonic anhydrase after diethylstilbestrol as a postcoital antifertility agent
Check et al. Improved implantation and live delivered pregnancy rates following transfer of embryos derived from donor oocytes by single injection of leuprolide in mid-luteal phase
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
Chakalova et al. Cancer burden of breast and gynecological cancers in Bulgaria: epidemiology and clinical aspects
ATE470669T1 (de) D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere
Simo et al. The impact of sexual activity during the third trimester of pregnancy on labor outcome in nulliparous women
Guttmacher Oral contraception
Dávila et al. Dual Protection Contraception Among South African Women
Rageh et al. The Association between Serum Estradiol and Progesterone on the Same Day of FET and the Pregnancy Outcome, a cross-sectional study
Di Carlo et al. LEPTIN AND MENOPAUSE

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees